Earnings Outlook For Akebia Therapeutics
Portfolio Pulse from Benzinga Insights
Akebia Therapeutics (NASDAQ:AKBA) is set to release its latest quarterly earnings report on August 25, 2023. Analysts estimate an EPS of $-0.02. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price the following day. The company's shares are currently trading at $1.29 and have seen a 240.61% increase over the last 52-week period.
August 24, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Akebia Therapeutics is expected to report an EPS of $-0.02 in its upcoming earnings report. Despite a history of beating EPS estimates, the company's share price often drops post-announcement.
Akebia Therapeutics has a history of beating EPS estimates but experiencing a drop in share price the following day. This trend, if continued, could negatively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100